Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
11.68
+0.33 (2.86%)
At close: Oct 15, 2025, 4:00 PM EDT
11.49
-0.19 (-1.58%)
After-hours: Oct 15, 2025, 7:59 PM EDT
Galecto Market Cap
Galecto has a market cap or net worth of $15.46 million as of October 15, 2025. Its market cap has increased by 21.69% in one year.
Market Cap
15.46M
Enterprise Value
5.08M
1-Year Change
21.69%
Ranking
Category
Stock Price
$11.68
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $15.46M, a decrease of -95.81%. That is a compound annual growth rate of -47.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 15.03M | 145.49% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | 368.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.28B |
| Johnson & Johnson | 459.63B |
| AbbVie | 404.77B |
| UnitedHealth Group | 325.98B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 231.95B |